The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-((S)-1-(((1R,2R)-2-(benzyloxy)-1-cyanopropyl)amino)-3-(3-bromophenyl)-1-oxopropan-2-yl)-3-(pyridin-3-yl)benzamide ID: ALA4741290
PubChem CID: 162647006
Max Phase: Preclinical
Molecular Formula: C32H29BrN4O3
Molecular Weight: 597.51
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: C[C@@H](OCc1ccccc1)[C@@H](C#N)NC(=O)[C@H](Cc1cccc(Br)c1)NC(=O)c1cccc(-c2cccnc2)c1
Standard InChI: InChI=1S/C32H29BrN4O3/c1-22(40-21-23-8-3-2-4-9-23)30(19-34)37-32(39)29(17-24-10-5-14-28(33)16-24)36-31(38)26-12-6-11-25(18-26)27-13-7-15-35-20-27/h2-16,18,20,22,29-30H,17,21H2,1H3,(H,36,38)(H,37,39)/t22-,29+,30-/m1/s1
Standard InChI Key: MECMHMVDUUQHDR-ZDERHKTGSA-N
Molfile:
RDKit 2D
40 43 0 0 0 0 0 0 0 0999 V2000
4.8536 -5.4521 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.5655 -5.0393 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2732 -5.4521 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2732 -6.2734 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.9850 -5.0393 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.6935 -5.4466 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6950 -6.2638 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4034 -6.6711 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.4049 -7.4883 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1134 -7.8956 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1117 -8.7137 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8193 -9.1209 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5272 -8.7109 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5231 -7.8895 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8149 -7.4860 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5665 -4.2222 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2747 -3.8145 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9800 -4.2276 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6877 -3.8205 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6892 -3.0025 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9771 -2.5931 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2722 -3.0025 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4004 -5.0367 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9880 -6.6737 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1051 -4.6262 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.1452 -5.0448 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1437 -4.2276 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.4382 -5.4547 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7326 -5.0456 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0261 -5.4548 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0271 -6.2728 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7406 -6.6800 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4441 -6.2684 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7459 -7.4945 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0388 -7.9063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0428 -8.7227 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7532 -9.1284 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4611 -8.7116 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.4535 -7.8965 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9752 -1.7760 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 2 0
3 5 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 10 1 0
2 16 1 1
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
6 23 1 6
7 24 1 6
23 25 3 0
1 26 1 0
26 27 2 0
26 28 1 0
28 29 2 0
29 30 1 0
30 31 2 0
31 32 1 0
32 33 2 0
33 28 1 0
34 35 2 0
35 36 1 0
36 37 2 0
37 38 1 0
38 39 2 0
39 34 1 0
32 34 1 0
21 40 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 597.51Molecular Weight (Monoisotopic): 596.1423AlogP: 5.47#Rotatable Bonds: 11Polar Surface Area: 104.11Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: 2HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): 2CX Acidic pKa: 11.41CX Basic pKa: 4.72CX LogP: 5.21CX LogD: 5.21Aromatic Rings: 4Heavy Atoms: 40QED Weighted: 0.24Np Likeness Score: -0.72
References 1. Cianni L,Rocho FDR,Bonatto V,Martins FCP,Lameira J,Leitão A,Montanari CA,Shamim A. (2021) Design, synthesis and stepwise optimization of nitrile-based inhibitors of cathepsins B and L., 29 [PMID:33254069 ] [10.1016/j.bmc.2020.115827 ]